-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation